CSTONE PHARMA-B (02616.HK) -0.190 (-3.399%) announced on July 8 that it has entered into an agreement with a placing agent to place a total of 100 million new shares (about 6.83% of the company's enlarged issued share capital) at a placing price of HKD4.72 per share, representing a discount of around 8.88% to the previous closing price of HKD5.18.The placement is expected to raise about HKD472 million, with net proceeds of about HKD467 million after expenses.(HK stocks quote is delayed for at least 15 mins.)Related NewsG Sachs: Out-licensing Trend in CN Biopharma Products Structural; SINO BIOPHARM TP Raised to HKD6.19